Activation of the GLP-1 receptor in microglia, GABAergic interneurons and astrocytes stimulates several intracellular pathways including the PI3K/Akt, cAMP/PKA/CREB, and P-Akt/p-eNOS and subsequently confers neuroprotective effects through inhibition of gp91/CHOP, Nrf2/HO-1, Bax/Bcl-2/caspase3/PARP, NF-B/ICAM-1, and JAK2/STAT3
Yes, semaglutide has received approval from health authorities in some regions for weight management in individuals without diabetes
Mental health monitoring is recommended during therapy, and you should continue any existing depression treatments unless advised otherwise
In addition, studies indicate a reduction in oxidative stress markers within affected tissues
Mechanism of action Qsymia works through central nervous system stimulation